About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 622 record(s)
Req # A-2022-00188
Tribute (Cobourg) Limited purchase of PT LT 13 CON 1 HAMILTON PT 2, 39R2207; COBOURGOrganization: Canadian Food Inspection Agency
February 2023
Req # A-2022-00191
Purchase of 2109 Lawrence Avenue West, Toronto, OntarioOrganization: Canadian Food Inspection Agency
February 2023
Req # A-2022-00192
Information on the total amount of spending on the program to regulate the size of diced canned potatoes each year, with cost broken down into salaries, procurement, and any reviews or consultations for the calendar years of 2020, 2021, and 2022.Organization: Canadian Food Inspection Agency
February 2023
Req # A-2019-001211
Adverse Drug Reactions (ADRs). Report numbers: E2B_02091013, E2B_02002505, E2B_02002388, E2B_02093588, E2B_02037631, 000721684, E2B_02009483, E2B_02005339, E2B_02012354, E2B_02015506, E2B_02015657, E2B_02112431, E2B_02091166, E2B_02091326,…Organization: Health Canada
February 2023
Req # A-2019-001330
Adverse Drug Reactions (ADRs) for . Report numbers: 000492644, E2B_01131309, E2B_01905011, E2B_01393817, E2B_01393818 E2B_01393819, E2B_01393825, 000684899, 000684971, E2B_00923241, E2B_00934370, E2B_00921359.Organization: Health Canada
February 2023
Req # A-2021-000221
Adverse Drug Reactions (ADRs). Report numbers: E2B_03673759, E2B_03703115, E2B_03703624, E2B_03703639, E2B_03706875, 000933420, E2B_02378938, 000934198, 000932984, 000933738, 000934453, 000935436, E2B_03696293, 000935252, E2B_03590665, E2B_03693011…Organization: Health Canada
February 2023
Req # A-2021-000357
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-103211-284.Organization: Health Canada
February 2023
Req # A-2021-000379
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102743-555.Organization: Health Canada
February 2023
Req # A-2021-001185
Adverse Drug Reactions (ADRs) for Veltassa. Report numbers: 000955192, 000955225. ADR for Abilify. Report number: E2B_04230011. ADRs for Abilify maintena. Report numbers: E2B_04319473, 000954222. ADRs for Aripiprazole. Report numbers: E2B_04344156,…Organization: Health Canada
February 2023
Req # A-2021-001212
Adverse Drug Reactions (ADRs) for Furosemide. Report numbers: E2B_02329595, E2B_02332753, E2B_02465756, E2B_02666597, E2B_02700545, E2B_02735447, E2B_02862291, E2B_02938406, E2B_03084996, E2B_03107034, E2B_03170465, E2B_03210414, E2B_03224674,…Organization: Health Canada
February 2023